Vijay Kedia has hand-picked a fail-safe blue-chip small-cap stock which is on a disruptive and exciting phase of growth. It is a first-mover and is expected to have minimum one-third market share of a Billion dollar industry
Subscribe to Blog via Email
Join 493 other subscribers
- Power Grid is trading at attractive valuation with dividend yield of 4.3%. TP ₹426 (36%)Power Grid has 50-60% market share in Inter-State Transmission Systems. Total capex potential is ₹6.6T. It is well placed to execute 6 upcoming HVDC & 3 cross-border projects. Co is trading at attractive valuation with dividend yield of 4.3%. TP ₹426 (36%) Download research report... Power Grid is trading at attractive valuation with dividend yield […]
- AVALON's long-term revenue trajectory will continue to be strong. TP ₹920 (+30%)AVALON's long-term revenue trajectory will continue to be strong due to 1) the addition of new customers in the US & Indian markets & 2) order inflows from high-growth/high-margin industries such as Clean Energy, Mobility & Industrials. TP ₹920 (+30%) Download research report... AVALON's long-term revenue trajectory will continue to be strong. TP ₹920 (+30%)
- Yatharth is trading at comforting valuations. Buy for TP ₹790 (30%)Yatharth is trading at comforting valuations. Given significant growth opportunities in local market & its pledge to increase revenue without sacrificing return ratios, there's a clear sign that gap in valuation from peers is likely to wane. TP ₹790 (30%) Download research report ... Yatharth is trading at comforting valuations. Buy for TP ₹790 (30%)
Recent Posts
- Power Grid is trading at attractive valuations with a dividend yield of 4.3%. Buy for target price of ₹426 (36% upside): Motilal Oswal
- Saurabh Mukherjea’s Marcellus Fund has added 5 stocks to the Rising Giants PMS portfolio
- Avalon Technologies is expected to show strong revenue and profitability. Buy for target price of ₹920 (+30% upside): Motilal Oswal
- Yatharth Hospital has significant growth opportunities. Buy for target price of ₹790 (30% upside): SMIFS
- J.B. Chemicals is well-positioned to capitalize on immediate growth opportunities. Buy for target price of ₹2217 (19% upside): SMIFS
Recent Comments